241467 ⎘
Drug, bio-affecting and body treating compositions involving immunoglobulin or antibody fragment, e.g. fab', fv, fc, heavy chain or light chain
ANTI-PCSK9 ANTIBODIES
#2Anti-PCSK9 antibodies
#3Anti-PCSK9 antibodies
#4ANTIBODIES AGAINST CLOSTRIDIUM DIFFICILE TOXINS AND USES THEREOF
#5Methods of treating cancer with low density lipoprotein-related protein 6 (LRP6)—half life extender constructs
#6Antibodies against clostridium difficile toxins and uses thereof
#7Low density lipoprotein-related protein 6 (LRP6)-half life extender constructs
#8Method for inhibiting cancer metastasis by administration of the extracellular domain DLK1 or a DLK1-FC fusion protein
#9Compositions and methods for increasing serum half-life
#10Agonist antibody to human thrombopoietin receptor
#11Reducing the immunogenicity of fusion proteins
#12Antibodies against clostridium difficile toxins and uses thereof
#13Compositions of F(ab′)antibody fragments
#14Agonist antibody to human thrombopoietin receptor
#15Prenatal enzyme replacement therapy for hypophosphatasia
#16High affinity human antibodies to PCSK9
#17Antibodies against toxins and uses thereof
#18Antibodies against clostridium difficile toxins and uses thereof
#19High affinity human antibodies to PCSK9
#20Human beta-glucuronidase mutants with elevated enzymatic activity under physiological conditions and method for identifying such
#21Reducing the immunogenicity of fusion proteins
#22Agonist antibody to human thrombopoietin receptor
#23Method for producing antibodies
#24Pharmaceutical composition of F(ab′)antibody fragments and a process for the preparation thereof
#25ANTI-LYMPHOTOXIN-BETA RECEPTOR ANTIBODIES AS ANTI-TUMOR AGENTS
#26Antibodies That Specifically Bind to Neurokinin B
#27Treatment of hematologic disorders
#28Monovalent ligand of the FcαRI receptor as an anti-inflammatory agent
#29Method of detecting an antibody in a liquid sample
#30Method for generating F(ab′)2 antibody fragments
#31Feline immunoglobulin E molecules and related methods
#32Receptor specific transepithelial transport of therapeutics
#33Reducing the immunogenicity of fusion proteins
#34Antibodies against toxins and uses thereof
#35Anti-lymphotoxin-β receptor antibodies as anti-tumor agents
#36Method of detecting an antibody in a liquid sample
#37Treatment of complement-associated disorders
#38Compositions, methods and kits relating to anti-platelet autoantibodies and inhibitors thereof
#39Antibodies that specifically bind to neurokinin B
#40Specific binding proteins including antibodies which bind to the necrotic centre of tumours, and uses thereof